Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Translate Bio stock | $37.36

Learn how to easily invest in Translate Bio stock.

Translate Bio Inc is a biotechnology business based in the US. Translate Bio shares (TBIO) are listed on the NASDAQ and all prices are listed in US Dollars. Translate Bio employs 122 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Translate Bio

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TBIO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Translate Bio stock price (NASDAQ: TBIO)

Use our graph to track the performance of TBIO stocks over time.

Translate Bio shares at a glance

Information last updated 2021-10-14.
Latest market close$37.36
52-week range$12.51 - $37.99
50-day moving average $37.53
200-day moving average $25.48
Wall St. target price$32.57
PE ratio 70.6238
Dividend yield N/A (0%)
Earnings per share (TTM) $0.53

Buy Translate Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Translate Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Translate Bio price performance over time

Historical closes compared with the close of $37.36 from 2021-09-14

1 week (2021-10-13) N/A
1 month (2021-09-20) N/A
3 months (2021-07-23) 24.53%
6 months (2021-04-23) 72.88%
1 year (2020-10-23) 166.29%
2 years (2019-10-23) 315.57%
3 years (2018-10-23) 584.25%
5 years (2016-10-20) N/A

Is Translate Bio under- or over-valued?

Valuing Translate Bio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Translate Bio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Translate Bio's P/E ratio

Translate Bio's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 71x. In other words, Translate Bio shares trade at around 71x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Translate Bio's EBITDA

Translate Bio's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $45.1 million.

The EBITDA is a measure of a Translate Bio's overall financial performance and is widely used to measure a its profitability.

Translate Bio financials

Revenue TTM $225.1 million
Operating margin TTM 18.52%
Gross profit TTM $79.3 million
Return on assets TTM 3.83%
Return on equity TTM 11.83%
Profit margin 17.97%
Book value $5.48
Market capitalisation $2.8 billion

TTM: trailing 12 months

Shorting Translate Bio shares

There are currently 4.3 million Translate Bio shares held short by investors – that's known as Translate Bio's "short interest". This figure is 43.2% up from 3.0 million last month.

There are a few different ways that this level of interest in shorting Translate Bio shares can be evaluated.

Translate Bio's "short interest ratio" (SIR)

Translate Bio's "short interest ratio" (SIR) is the quantity of Translate Bio shares currently shorted divided by the average quantity of Translate Bio shares traded daily (recently around 5.8 million). Translate Bio's SIR currently stands at 0.74. In other words for every 100,000 Translate Bio shares traded daily on the market, roughly 740 shares are currently held short.

However Translate Bio's short interest can also be evaluated against the total number of Translate Bio shares, or, against the total number of tradable Translate Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Translate Bio's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Translate Bio shares in existence, roughly 60 shares are currently held short) or 0.0882% of the tradable shares (for every 100,000 tradable Translate Bio shares, roughly 88 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Translate Bio.

Find out more about how you can short Translate Bio stock.

Translate Bio share dividends

We're not expecting Translate Bio to pay a dividend over the next 12 months.

Translate Bio share price volatility

Over the last 12 months, Translate Bio's shares have ranged in value from as little as $12.51 up to $37.985. A popular way to gauge a stock's volatility is its "beta".

TBIO.US volatility(beta: 0.97)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Translate Bio's is 0.9704. This would suggest that Translate Bio's shares are less volatile than average (for this exchange).

Translate Bio overview

Translate Bio, Inc. , a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis. It is also developing MRT5500 for the treatment of SARS-CoV-2. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017.

Frequently asked questions

What percentage of Translate Bio is owned by insiders or institutions?
Currently 7.42% of Translate Bio shares are held by insiders and 95.451% by institutions.
How many people work for Translate Bio?
Latest data suggests 122 work at Translate Bio.
When does the fiscal year end for Translate Bio?
Translate Bio's fiscal year ends in December.
Where is Translate Bio based?
Translate Bio's address is: 29 Hartwell Avenue, Lexington, MA, United States, 02421
What is Translate Bio's ISIN number?
Translate Bio's international securities identification number is: US89374L1044
What is Translate Bio's CUSIP number?
Translate Bio's Committee on Uniform Securities Identification Procedures number is: 89374L104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site